BSEBoard Meeting28 Oct 2026 · 28 Oct 2026, 12:42 pm

Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial results of the Company for the quarter and half year ended September 30, 2026

Anthem Biosciences Ltd · 544449

✦ AI SummaryResults

Anthem Biosciences Ltd has scheduled a board meeting on November 3, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Anthem Biosciences Ltd - 544449 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026

Attachments (1)

📄

401c0eac-d7f7-42e0-8623-039c5ef1cb0f.pdf

pdf

Download →
View document text
Date: October 28, 2026 BSE Limited, National Stock Exchange of India Limited 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544449 NSE Scrip Symbol: ANTHEM Subject: Intimation of the Board Meeting, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015 Dear Sir/Ma’am This is to inform you that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of Anthem Biosciences Limited (“the Company”) is scheduled to be held on Tuesday, November 03, 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. In furtherance to our previous letter dated September 24, 2026, the trading window for dealing in Equity Shares of the Company has been closed from October 01, 2026 till close of trading hours of November 05, 2026 i.e. until 48 (Forty-Eight) hours after the declaration of the financial results of the Company for the quarter and half year ended September 30, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct to regulate, monitor, and report trading by Employees and other Connected person. The above intimation is also available on the Company’s website at https://anthembio.com/. We request you to kindly take the same on record. Thanking you, Yours truly, For Anthem Biosciences Limited (Formerly known as Anthem Biosciences Private Limited) Divya Prasad Company Secretary & Compliance Officer Membership No: A41438